Class information for:
Level 1: HEPATITIS B IMMUNOGLOBULIN//HBIG//HEPATITIS B RECURRENCE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11434 916 28.6 85%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
124 23152 HEPATITIS B VIRUS//CHRONIC HEPATITIS B//HEPATITIS B

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HEPATITIS B IMMUNOGLOBULIN Author keyword 33 57% 4% 39
2 HBIG Author keyword 31 71% 3% 25
3 HEPATITIS B RECURRENCE Author keyword 31 92% 1% 12
4 HEPATITIS B IMMUNE GLOBULIN Author keyword 22 63% 2% 22
5 DE NOVO HEPATITIS B Author keyword 9 83% 1% 5
6 HBV RECURRENCE Author keyword 8 60% 1% 9
7 HEPATITIS B IMMUNOGLOBULINS Author keyword 8 100% 1% 5
8 HEPATITIS B VIRUS RECURRENCE Author keyword 8 100% 1% 5
9 HEPATITIS B CORE ANTIBODY Author keyword 8 50% 1% 11
10 DE NOVO HBV INFECTION Author keyword 6 71% 1% 5

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HEPATITIS B IMMUNOGLOBULIN 33 57% 4% 39 Search HEPATITIS+B+IMMUNOGLOBULIN Search HEPATITIS+B+IMMUNOGLOBULIN
2 HBIG 31 71% 3% 25 Search HBIG Search HBIG
3 HEPATITIS B RECURRENCE 31 92% 1% 12 Search HEPATITIS+B+RECURRENCE Search HEPATITIS+B+RECURRENCE
4 HEPATITIS B IMMUNE GLOBULIN 22 63% 2% 22 Search HEPATITIS+B+IMMUNE+GLOBULIN Search HEPATITIS+B+IMMUNE+GLOBULIN
5 DE NOVO HEPATITIS B 9 83% 1% 5 Search DE+NOVO+HEPATITIS+B Search DE+NOVO+HEPATITIS+B
6 HBV RECURRENCE 8 60% 1% 9 Search HBV+RECURRENCE Search HBV+RECURRENCE
7 HEPATITIS B IMMUNOGLOBULINS 8 100% 1% 5 Search HEPATITIS+B+IMMUNOGLOBULINS Search HEPATITIS+B+IMMUNOGLOBULINS
8 HEPATITIS B VIRUS RECURRENCE 8 100% 1% 5 Search HEPATITIS+B+VIRUS+RECURRENCE Search HEPATITIS+B+VIRUS+RECURRENCE
9 HEPATITIS B CORE ANTIBODY 8 50% 1% 11 Search HEPATITIS+B+CORE+ANTIBODY Search HEPATITIS+B+CORE+ANTIBODY
10 DE NOVO HBV INFECTION 6 71% 1% 5 Search DE+NOVO+HBV+INFECTION Search DE+NOVO+HBV+INFECTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 COMBINATION LAMIVUDINE 113 91% 5% 48
2 PASSIVE IMMUNOPROPHYLAXIS 102 83% 6% 58
3 VIRUS RECURRENCE 95 70% 9% 78
4 HBSAG POSITIVE PATIENTS 71 77% 5% 48
5 GRAFT REINFECTION 61 78% 4% 40
6 LONG TERM IMMUNOPROPHYLAXIS 51 91% 2% 21
7 HBV RECURRENCE 45 94% 2% 16
8 IMMUNOPROPHYLAXIS 25 30% 8% 72
9 HBIG 23 74% 2% 17
10 IMMUNE GLOBULIN 23 11% 22% 201

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Safe and cost-effective control of post-transplantation recurrence of hepatitis B 2015 2 65 85%
Liver grafts from anti-hepatitis B core positive donors: A systematic review 2010 70 44 86%
Hepatitis B Immunoglobulin and/or Nucleos(t)ide Analogues for Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review 2011 29 62 94%
Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review 2000 131 67 61%
Current management of hepatitis B virus infection before and after liver transplantation 2009 26 95 75%
Liver Transplantation in Delta Virus Infection 2012 7 61 85%
Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature 2010 14 37 92%
Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review 2010 14 53 89%
Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation 2012 6 58 83%
Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update 2012 4 82 93%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GASTROENTEROLKANGNAM KU 2 67% 0.2% 2
2 L AROSCOP HEPAT LIVER TRANSPLANT UNIT 2 67% 0.2% 2
3 MINIST PUBL HLTH ORGAN TRANSPLANTAT 2 67% 0.2% 2
4 VICTORIAN LIVER TRANSPLANT UNIT 1 25% 0.5% 5
5 OCHSNER MULTI ORGAN TRANSPLANT 1 100% 0.2% 2
6 IMMUNOPROPHYLAXIS 1 29% 0.4% 4
7 SURGKANGNAM KU 1 33% 0.3% 3
8 HIPPOKRAT GEN HOSP THESSALONIKI 1 20% 0.5% 5
9 MEDGASTROENTEROL UNIT 1 40% 0.2% 2
10 U 785 1 33% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000179431 HEPATITIS C RECURRENCE//RECURRENT HEPATITIS C//HCV RECURRENCE
2 0.0000161965 CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE
3 0.0000153952 HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION
4 0.0000111268 LIVER KIDNEY DIS TRANSPLANTAT//HCV VIREMIA//NOSOCOMIAL TRANSMISSION
5 0.0000107743 OCCULT HBV INFECTION//ANTI HBC//OCCULT HEPATITIS B VIRUS INFECTION
6 0.0000105162 HIGH RISK DONOR//DONOR DERIVED INFECTION//DONOR TO HOST TRANSMISSION
7 0.0000086502 HEPATITIS B VIRUS//PRECORE//PRECORE MUTATION
8 0.0000082681 LYMPHOCYTOTOXIC CROSSMATCH//ANNETTE C HAROLD C SIMMONS TRANSPLANT//LIVER ALLOGRAFT REJECTION
9 0.0000056153 MILAN CRITERIA//UCSF CRITERIA//SALVAGE LIVER TRANSPLANTATION
10 0.0000053903 MELD//MODEL FOR END STAGE LIVER DISEASE//DONOR RISK INDEX